Global Coronary Artery Bypass Grafts (CABG) Market Growth (Status and Outlook) 2023-2029

Global Coronary Artery Bypass Grafts (CABG) Market Growth (Status and Outlook) 2023-2029

Product Code:455456

Published Date: Feb 08,2023

Pages: 89

Region: Global

Category: Pharma & Healthcare

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US

Coronary artery bypass surgery, also known as coronary artery bypass graft (CABG) surgery, and colloquially heart bypass or bypass surgery, is a surgical procedure to restore normal blood flow to an obstructed coronary artery.

LPI (LP Information)' newest research report, the “Coronary Artery Bypass Grafts (CABG) Industry Forecast” looks at past sales and reviews total world Coronary Artery Bypass Grafts (CABG) sales in 2022, providing a comprehensive analysis by region and market sector of projected Coronary Artery Bypass Grafts (CABG) sales for 2023 through 2029. With Coronary Artery Bypass Grafts (CABG) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Coronary Artery Bypass Grafts (CABG) industry.

This Insight Report provides a comprehensive analysis of the global Coronary Artery Bypass Grafts (CABG) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Coronary Artery Bypass Grafts (CABG) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Coronary Artery Bypass Grafts (CABG) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Coronary Artery Bypass Grafts (CABG) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Coronary Artery Bypass Grafts (CABG).

The global Coronary Artery Bypass Grafts (CABG) market size is projected to grow from US$ 125.7 million in 2022 to US$ 181.6 million in 2029; it is expected to grow at a CAGR of 5.4% from 2023 to 2029.

Global Coronary Artery Bypass Grafts (CABG) key players include Medtronic, Getinge Group, LivaNova, Terumo, Boston Scientific, etc. Global top five manufacturers hold a share about 65%.

North America is the largest market, with a share over 35%, followed by Europe and Asia-Pacific, both have a share about 55 percent. 
In terms of product, Saphenous Vein Grafts is the largest segment, with a share about 70%. And in terms of application, the largest application is Traditional CABG, followed by Nontraditional CABG.

This report presents a comprehensive overview, market shares, and growth opportunities of Coronary Artery Bypass Grafts (CABG) market by product type, application, key players and key regions and countries.

Market Segmentation:
Segmentation by type
    Saphenous Vein Grafts
    Internal Thoracic Artery Grafts
    Other

Segmentation by application
    Traditional CABG
    Nontraditional CABG

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    Medtronic
    Getinge Group
    LivaNova
    Terumo
    Boston Scientific
    Stryker
    Edwards Lifesciences
    Genesee Biomedical
    Karl Storz GmbH